Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human ALDH1A3 ELISA Kit (AC3437)
Cat.#: ASET-2026
Specifications
Description Human ALDH1A3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human ALDH1A3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.31 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2380 Human PEDF ELISA Kit (AC3791) Quantitative inquiry ASET-2084 Mouse PEDF ELISA Kit (AC3495) Quantitative inquiry ASET-2120 Rat ARNT2 ELISA Kit (AC3531) Quantitative inquiry ASET-2510 Mouse beta 1 Adrenergic Receptor ELISA Kit (AC3921) Quantitative inquiry ASET-1809 Human Ephrin B2 ELISA Kit (AC3220) Quantitative inquiry ASET-1376 Human TPP1 ELISA Kit (AC2787) Quantitative inquiry ASET-2257 GABA ELISA Kit (AC3668) Quantitative inquiry ASET-1341 Chicken Acetylcholinesterase ELISA Kit (AC2752) Quantitative inquiry ASET-1246 Human Claudin 14 ELISA Kit (AC2657) Quantitative inquiry ASET-1832 Human NCAM1 ELISA Kit (AC3243) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket